Allelica powers PROACT 3 clinical trial with multi-ancestry polygenic risk score testing

SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- Allelica, the global leader in multi-ancestry clinical polygenic risk score (PRS) testing, has been selected as the PRS testing collaborator for the PROACT 3 clinical trial at Mass General Brigham. Led by principal investigator Dr. Akl Fahed of...